NasdaqGS - Delayed Quote USD

Omnicell, Inc. (OMCL)

28.43 +0.25 (+0.89%)
At close: April 23 at 4:00 PM EDT
28.43 0.00 (0.00%)
After hours: April 23 at 4:02 PM EDT
Loading Chart for OMCL
DELL
  • Previous Close 28.18
  • Open 28.00
  • Bid 28.40 x 200
  • Ask 28.51 x 100
  • Day's Range 27.85 - 29.31
  • 52 Week Range 25.69 - 77.14
  • Volume 429,632
  • Avg. Volume 567,825
  • Market Cap (intraday) 1.306B
  • Beta (5Y Monthly) 0.76
  • PE Ratio (TTM) --
  • EPS (TTM) -0.45
  • Earnings Date May 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 34.50

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

www.omnicell.com

3,650

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OMCL

Performance Overview: OMCL

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OMCL
24.45%
S&P 500
6.30%

1-Year Return

OMCL
54.33%
S&P 500
22.67%

3-Year Return

OMCL
79.36%
S&P 500
22.63%

5-Year Return

OMCL
60.57%
S&P 500
74.37%

Compare To: OMCL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OMCL

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    1.29B

  • Enterprise Value

    1.43B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.11

  • Price/Book (mrq)

    1.09

  • Enterprise Value/Revenue

    1.25

  • Enterprise Value/EBITDA

    23.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.78%

  • Return on Assets (ttm)

    -0.61%

  • Return on Equity (ttm)

    -1.76%

  • Revenue (ttm)

    1.15B

  • Net Income Avi to Common (ttm)

    -20.37M

  • Diluted EPS (ttm)

    -0.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    467.97M

  • Total Debt/Equity (mrq)

    51.65%

  • Levered Free Cash Flow (ttm)

    114.58M

Research Analysis: OMCL

Analyst Price Targets

26.00 Low
34.50 Average
28.43 Current
40.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: OMCL

Fair Value

28.43 Current
 

Dividend Score

0 Low
OMCL
Sector Avg.
100 High
 

Hiring Score

0 Low
OMCL
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
OMCL
Sector Avg.
100 High
 

Research Reports: OMCL

  • OMCL: Lowering target price to $21.00

    OMNICELL INC has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • OMCL: Raising target price to $23.00

    OMNICELL INC has an Investment Rating of SELL; a target price of $23.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • OMCL: What does Argus have to say about OMCL?

    OMNICELL INC has an Investment Rating of SELL; a target price of $22.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • OMCL: What does Argus have to say about OMCL?

    OMNICELL INC has an Investment Rating of SELL; a target price of $22.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch